These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31479419)

  • 21. Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models.
    van Eersel J; Ke YD; Liu X; Delerue F; Kril JJ; Götz J; Ittner LM
    Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13888-93. PubMed ID: 20643941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive deficits are ameliorated by reduction in amyloid β accumulation in Tg2576/p75(NTR+/-) mice.
    Jian C; Zou D; Luo C; Liu X; Meng L; Huang J; Li X; Huang R; Wu Y
    Life Sci; 2016 Jun; 155():167-73. PubMed ID: 27165536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease.
    Zhu C; Xu B; Sun X; Zhu Q; Sui Y
    Mol Neurobiol; 2017 Dec; 54(10):7964-7978. PubMed ID: 27878757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of the immunostainable length of the hippocampal dentate granule cells' primary cilia in 3xAD-transgenic mice producing human Aβ(1-42) and tau.
    Chakravarthy B; Gaudet C; Ménard M; Brown L; Atkinson T; Laferla FM; Ito S; Armato U; Dal Prà I; Whitfield J
    Biochem Biophys Res Commun; 2012 Oct; 427(1):218-22. PubMed ID: 22995307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice.
    Rhein V; Song X; Wiesner A; Ittner LM; Baysang G; Meier F; Ozmen L; Bluethmann H; Dröse S; Brandt U; Savaskan E; Czech C; Götz J; Eckert A
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20057-62. PubMed ID: 19897719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substrate-specific reduction of PP2A activity exaggerates tau pathology.
    Deters N; Ittner LM; Götz J
    Biochem Biophys Res Commun; 2009 Feb; 379(2):400-5. PubMed ID: 19126401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
    J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease.
    Peng Y; Hu Y; Xu S; Rong X; Li J; Li P; Wang L; Yang J; Wang X
    J Pharmacol Exp Ther; 2014 Aug; 350(2):361-74. PubMed ID: 24893984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
    Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ
    J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.
    Perez SE; Getova DP; He B; Counts SE; Geula C; Desire L; Coutadeur S; Peillon H; Ginsberg SD; Mufson EJ
    Am J Pathol; 2012 Feb; 180(2):526-40. PubMed ID: 22142809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease.
    Li SQ; Yu Y; Han JZ; Wang D; Liu J; Qian F; Fan GH; Bucala R; Ye RD
    J Neuroinflammation; 2015 Sep; 12():177. PubMed ID: 26382037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. proBDNF is modified by advanced glycation end products in Alzheimer's disease and causes neuronal apoptosis by inducing p75 neurotrophin receptor processing.
    Fleitas C; Piñol-Ripoll G; Marfull P; Rocandio D; Ferrer I; Rampon C; Egea J; Espinet C
    Mol Brain; 2018 Nov; 11(1):68. PubMed ID: 30428894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling.
    Yaar M; Zhai S; Fine RE; Eisenhauer PB; Arble BL; Stewart KB; Gilchrest BA
    J Biol Chem; 2002 Mar; 277(10):7720-5. PubMed ID: 11756426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576.
    Chauhan NB; Siegel GJ; Feinstein DL
    Neuropharmacology; 2005 Jan; 48(1):93-104. PubMed ID: 15617731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The killing of neurons by beta-amyloid peptides, prions, and pro-inflammatory cytokines.
    Chiarini A; Dal Pra I; Whitfield JF; Armato U
    Ital J Anat Embryol; 2006; 111(4):221-46. PubMed ID: 17385278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholinergic Basal Forebrain Lesion Decreases Neurotrophin Signaling without Affecting Tau Hyperphosphorylation in Genetically Susceptible Mice.
    Turnbull MT; Coulson EJ
    J Alzheimers Dis; 2017; 55(3):1141-1154. PubMed ID: 27767994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of proneurotrophins and activation of p75NTR-mediated apoptosis via neurotrophin receptor-interacting factor in hippocampal neurons after seizures.
    Volosin M; Trotter C; Cragnolini A; Kenchappa RS; Light M; Hempstead BL; Carter BD; Friedman WJ
    J Neurosci; 2008 Sep; 28(39):9870-9. PubMed ID: 18815271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of p75 Neurotrophin Receptor Involvement in the Central Nervous System Pathogenesis of Classical Scrapie in Sheep and a Transgenic Mouse Model.
    Barrio T; Vidal E; Betancor M; Otero A; Martín-Burriel I; Monzón M; Monleón E; Pumarola M; Badiola JJ; Bolea R
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice.
    Xiong J; Deng I; Kelliny S; Lin L; Bobrovskaya L; Zhou XF
    Metab Brain Dis; 2022 Aug; 37(6):1941-1957. PubMed ID: 35704147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.